-
NYU Dataset
MPC309 Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-Resistant Prostate Cancer
- Authors
- Justine HabaultJeffrey A. SchneiderSusan HaRachel Ruoff14 more author(s)...
- Description
Prostate cancer cells depend on the androgen receptor (AR) for survival and proliferation. This study examined the antitumor effects of compound MPC309, a trivalent display of ethisterone conjugated to a peptoid oligomer backbone that binds to the AR with nanomolar affinity. First, a structure-activity relationship study was performed to improve multivalent peptoid conjugate potency. Then, the impact...
- Subject
-
CancerGenomics
- Access Rights
- Free to All